810 411

Cited 0 times in

Efficacy of clotinab in acute myocardial infarction trial-ST elevation myocardial infarction (ECLAT-STEMI)

Kim, JS; Park, SM; Kim, BK; Ko, YG; Choi, D; Hong, MK; Seong, IW; Kim, BO; Gwon, HC; Hong, BK; Tahk, SJ; Park, SW; Kim, CJ; Jeong, MH; Yoon, J; Jang, Y; ECLAT-STEMI Trial investigators
Circulation journal : official journal of the Japanese Circulation Society, 76(2):405-413, 2012
Journal Title
Circulation journal : official journal of the Japanese Circulation Society
BACKGROUND: This study investigated the efficacy and the safety of the upstream glycoprotein (Gp) IIb/IIIa inhibitor (clotinab; ISU ABXIS, Seoul, Republic of Korea) under 600-mg clopidogrel pretreatment compared with provisional use in ST-elevation myocardial infarction (STEMI).

METHODS AND RESULTS: A total of 786 STEMI patients were randomized to upstream use in the emergency room (ER) (n = 392) or provisional use during percutaneous coronary intervention (PCI) (n = 394). All patients were prescribed 600-mg clopidogrel in the ER. The primary endpoint was the 30-day incidence of composite events including death, nonfatal myocardial infarction, target vessel revascularization, and stroke. There was no significant difference in the events that occurred in 40 patients (10.2%) in the upstream arm and 55 patients (14.0%) in the provisional arm during the 30 days (odds ratio 0.70, 95% confidence interval 0.45-1.08). Major bleeding was higher in the upstream arm (1.5% vs. 0%, P = 0.02). However, there was a significant reduction in 30-day composite events in the upstream arm in the high-risk population (Killip class ≥II or GRACE score >140).

CONCLUSIONS: The upstream use of clotinab under a 600-mg clopidogrel loading may not significantly reduce cardiac events following primary PCI but may improve the clinical outcome in high-risk patients.
MeSH terms
Aged*Angioplasty, Balloon, Coronary/statistics & numerical dataAntibodies, Monoclonal/*administration & dosageCombined Modality TherapyCoronary AngiographyElectrocardiographyEmergency Medical Services/methods/statistics & numerical dataFemaleFollow-Up StudiesHumansImmunoglobulin Fab Fragments/*administration & dosageIncidenceKaplan-Meier EstimateMaleMiddle AgedMyocardial Infarction/diagnosis/*drug therapy/mortalityPlatelet Aggregation Inhibitors/*administration & dosageProspective StudiesRisk FactorsTreatment Outcome
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Cardiology
AJOU Authors
탁, 승제
Full Text Link
Files in This Item:
RIS (EndNote)
XLS (Excel)


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.